HNN3.0

Maven Health

Start-up

www.mavenhealth.chZurich, Switzerland

About

_Maven Health has developed a non-invasive metabolic profiling platform designed for prevention, early detection, and outcome monitoring in cardiometabolic and cardiovascular disease.
_
The platform builds on saliva-based small-molecule measurements and goes beyond classical metabolomics by translating biochemical signals into structured, functional metabolic profiles that reflect systemic metabolic and cardiometabolic states.

At the core of Maven Health’s approach is the integration of high-dimensional metabolic data with proprietary interpretation frameworks that link metabolic patterns to clinically and physiologically relevant processes. This enables sensitive detection of early metabolic dysregulation associated with cardiovascular risk, as well as longitudinal monitoring of metabolic responses to lifestyle interventions, therapies, or pharmacological treatments.

Maven Health provides end-to-end capabilities, from non-invasive sample collection and scalable molecular analysis to practitioner-ready metabolic profiles and user guides. These outputs are designed to be directly usable by healthcare professionals and researchers, supporting preventive screening, patient stratification, and the assessment of intervention effects over time. The platform is particularly suited for repeated measurements, making it well adapted to longitudinal studies and real-world evidence generation.

Within previous and ongoing collaborative research and innovation projects, Maven Health contributes a unique combination of non-invasive metabolic phenotyping, scalable analytics, and applied interpretation. This positions the company as expert in cardiovascular non-communicable diseases, prevention strategies, early detection, and the evaluation of treatment or lifestyle-related outcomes. By enabling objective, repeatable metabolic readouts, Maven Health supports the development of more effective, preventive, and patient-centered approaches to cardiovascular health.

Representatives

cofounder/CSO

Maven Health

Marketplace (1)

  • Project cooperation

    Saliva-based metabolomics platform & expertise for Horizon research and innovation projects

    We offer a non-invasive saliva-based metabolomics platform and deep expertise in NMR metabolomics and metabolic profiling.

    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
    Author

    cofounder/CSO at Maven Health

    Zurich, Switzerland